Inhibition of Insulin Secretion as a New Drug Target in the Treatment of Metabolic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|12|1595-1615

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.12, 2004-06, pp. : 1595-1615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Alkaline Phosphatase: An Emerging New Drug Target

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 41-51

Bentham Science Publishers

Access to resources Recommend Favorite

The Histamine H3 Receptor as a Therapeutic Drug Target for Metabolic Disorders: Status, Challenges and Opportunities

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1430-1446

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Induced Endocrine and Metabolic Disorders

By Chaker Ben Salem  

Drug Safety, Vol. 30, Iss. 8, 2007-01 ,pp. : 727-728

Adis International

Access to resources Recommend Favorite

Drug Treatment of Metabolic Syndrome

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-08 ,pp. : 224-231

Bentham Science Publishers

Access to resources Recommend Favorite

New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discovery

By Saxena Uday   Timmer Richard T   Pillarisetti Sivaram  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. : 539-545

Informa Healthcare

Access to resources Recommend Favorite